Opendata, web and dolomites

SUPRAVACC SIGNED

Supramolecular engineering of glycan-decorated peptides as synthetic vaccines

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUPRAVACC project word cloud

Explore the words cloud of the SUPRAVACC project. It provides you a very rough idea of what is the project "SUPRAVACC" about.

team    induction    mimetic    building    polymer    immunisations    synthetic    units    subunit    insights    molecular    gained    applicable    antibacterial    antigens    academic    facile    vaccine    candidates    grafted    combine    memory    unmet    antiviral    drive    lives    entities    paradigm    onto    particles    composition    carbohydrate    disease    multipotent    proteins    handling    self    peptides    antitumour    cancer    fundamental    supravacc    pathogens    decorated    assembling    diseases    platform    glycopeptide    precise    potent    protection    serve    shift    universal    industrial    glycan    laboratories    shelf    engineering    molecule    protein    broadly    stability    immunological    preparation    epitopes    limited    pioneer    formulations    blocks    countries    conjugation    pathogen    synthesise    designed    toolbox    conjugates    functionalisation    carrier    immunostimulants    pharmaceutical    nanoscaled    compounds    vaccinations    small    individually    supramolecular    employ    endogenous    modular    strategies    attach    radically    appended    vaccines    lack    minimalistic    suffer    construct   

Project "SUPRAVACC" data sheet

The following table provides information about the project.

Coordinator
JOHANNES GUTENBERG-UNIVERSITAT MAINZ 

Organization address
address: SAARSTRASSE 21
city: MAINZ
postcode: 55122
website: www.uni-mainz.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 2˙000˙000 €
 EC max contribution 2˙000˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-COG
 Funding Scheme ERC-COG
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2024-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    JOHANNES GUTENBERG-UNIVERSITAT MAINZ DE (MAINZ) coordinator 2˙000˙000.00

Map

 Project objective

The main and most important feature of vaccines is the induction of an immunological memory response, which is key to providing long-term protection against pathogens. The current strategies for potent antibacterial and antiviral vaccines employ conjugation of pathogen specific entities onto carrier proteins, and are limited to formulations that suffer from low stability and short shelf-lives, and are thus not viable in developing countries. Strategies for the development of new vaccinations against endogenous diseases like cancer further remain an unmet challenge, since current methodologies suffer from a lack of a modular and tailored vaccine-specific functionalisation. I therefore propose a radically new design approach in the development of fully synthetic molecular vaccines. My team will synthesise carbohydrate and glycopeptide appended epitopes that are grafted onto supramolecular building blocks. These units can be individually designed to attach disease specific antigens and immunostimulants. Due to their self-assembling properties into nanoscaled pathogen mimetic particles, they serve as a supramolecular subunit vaccine toolbox. By developing a universal supramolecular polymer platform, we will construct multipotent vaccines from glycan-decorated peptides, that combine the activity of protein conjugates with the facile handling, precise composition and increased stability of traditional small molecule pharmaceutical compounds. SUPRAVACC will pioneer the design of minimalistic and broadly applicable vaccines, and will evaluate the supramolecular engineering approach for immunisations against antibacterial diseases, as well as for applications as antitumour vaccine candidates. The fundamental insights gained will drive a paradigm shift in the design and preparation of vaccine candidates in academic and industrial research laboratories.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPRAVACC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPRAVACC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

SuperH (2019)

Discovery and Characterization of Hydrogen-Based High-Temperature Superconductors

Read More  

Photopharm (2020)

Photopharmacology: From Academia toward the Clinic.

Read More  

3DPRINTEDOPTICS (2019)

3D printed micro- and nano-optics for future integrated vision and endoscopy systems

Read More